Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. In these trials, passive administration of VRC01, a broadly neutralizing antibody against human immunodeficiency virus that targets the HIV CD4-binding site, had some anti-HIV effect in 24 persons with chronic HIV infection.